Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Drew Lambourne

Physician Assistant, Surgical Provo, UT Physician Assistant

NPI 1184930786 CMS profile 10651729

1055 N 500 W, Suite 121, Provo, UT 84604

Open in the dashboard

General payments

$4,210

101 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Drew Lambourne of Provo, UT is reported in the CMS Open Payments database as having received $4,210 across 101 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $897 13
2024 General $255 8
2023 General $437 12
2022 General $691 22
2021 General $1,930 46

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Drew Lambourne
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Drew Lambourne were reported at $897. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Drew Lambourne Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,930 $111 $36–$285 $132
2022 $691 $126 $44–$350 $149
2023 $437 $137 $47–$355 $160
2024 $255 $146 $49–$384 $164
2025 $897 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Stryker Corporation $2,451 59 payments
  2. Pacira Pharmaceuticals Incorporated $815 9 payments
  3. Flexion Therapeutics, Inc. $285 12 payments
  4. Medical Device Business Services, Inc. $227 2 payments
  5. DePuy Synthes Sales Inc. $124 2 payments
  6. Ferring Pharmaceuticals Inc. $93 5 payments
  7. Ethicon US, LLC $46 3 payments
  8. NextStep Arthropedix, LLC $34 1 payment
  9. Abbott Laboratories $30 2 payments
  10. Bioventus LLC $27 1 payment
  11. Other $80 5 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,537 98 payments
  2. Travel and Lodging $536 2 payments
  3. Education $137 1 payment
Products named General payments · program years 2021–2025
  1. MAKO $1,988 44 payments
  2. Iovera System $675 5 payments
  3. TRIATHLON $311 10 payments
  4. Zilretta $285 12 payments
  5. VIPER $115 1 payment
  6. SYNFIX Evolution $115 1 payment
  7. Exparel $109 3 payments
  8. MOTIONSENSE DIGITAL GONIOMETER $105 3 payments
  9. EUFLEXXA $93 5 payments
  10. STRATAFIX $46 3 payments
  11. Other $393 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

1,364

Median for Physician Assistant: 241

Drug cost

$6,905

Median for Physician Assistant: $4,110

Branded share of claims

0%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 309 $1,842
Meloxicam Generic 404 $1,744
Cyclobenzaprine Hcl Generic 212 $1,185
Cephalexin Generic 257 $1,020
Diclofenac Sodium Generic 21 $387
Ciprofloxacin Hcl Generic 64 $285
Methylprednisolone Generic 24 $136
Tramadol Hcl Generic 33 $135
Clindamycin Hcl Generic 23 $132
Amoxicillin Generic 17 $37

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$63,860

Of which drugs: $3,446

Medicare patients

216

Average age 74

Services billed

873

126 women, 90 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Ischemic heart disease 28%
Diabetes 20%
Chronic kidney disease 17%
Depression 15%
Atrial fibrillation 14%
Osteoporosis 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

101 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record